Disease Info Card

Diffuse Astrocytoma

Information about Diffuse Astrocytoma: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Diffuse Astrocytoma

Most recent studies have shown that Diffuse Astrocytoma shares some biological mechanisms with anaplastic-astrocytoma, astrocytoma, brain-neoplasms, cell-transformation-neoplastic, central-nervous-system-neoplasms, ependymoma, glioblastoma, glioblastoma-multiforme, glioma, malignant-glioma, malignant-neoplasms, malignant-paraganglionic-neoplasm, meningioma, mixed-oligodendroglioma-astrocytoma, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, nervousness, oligodendroglioma, pilocytic-astrocytoma.

Among the many pathways, these few ones have gauged particular interests from scientists studying Diffuse Astrocytoma, and have been seen in publications frequently: Angiogenesis, Brain Segmentation, Cell Adhesion, Cell Cycle, Cell Growth, Cell Migration, Cell Proliferation, Dedifferentiation, Dna Repair, Dna Replication, Humoral Immune Response, Immune Response, Localization, Methylation, Oncogenesis, Pathogenesis, Proteolysis, Reverse Transcription, Transposition

Quite a number of genes have been found to play important roles in Diffuse Astrocytoma, such as CDK4, CDKN1A, CDKN2A, CSF2, EGFR, GFAP, IDH1, IDH2, LAMC2, MGMT, MID1, MMP2, PCNA, PTEN, RB1, TEAD1, TGM1, TP53, VEGFA. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.